$AMTX

$AMTX going

AMTX - This has wide range so use LESS SIZE. Ideally 19.50 / 20.00 / 20.50 to short CTEK- 2.20 / 2.40 to short PALT - Started in some at 11, but plan to scale every 50 cents on this stock because it topped out yesterday DATS - Looking for 14.00 / 14.50 / 15 rejection to scale in short CEI - Will wait for a death candle then short the bounce. I think today is a dead cat bounce

$AMTX might trap

Upside: -ENOB +159% (announces FDA Acceptance of Pre-IND Request for Potential HIV Cure) -ITOS +51% (GSK and iTeos announce development and commercialisation collaboration for EOS-448) -CRSR +15% (hearing interest from WallStreetBets) -NVAX +9.0% (COVID-19 vaccine demonstrates 90% overall efficacy and 100% protection against moderate and severe disease in PREVENT-19 Phase 3 trial) -LPCN +8.3% (FDA clears LPCN 1154 IND application for a Phase 2 Postpartum Depression Study) -RIOT +8.3% (crypto strength following TSLA CEO Musk indicating car maker may resume BTC transactions) -HAPP +7.8% (signed agreement to distribute Volkswagen Electric Vehicles) -MARA +7.8% (crypto strength following TSLA CEO Musk indicating car maker may resume BTC transactions) -RAPT +7.7% (reports positive topline results from Phase 1b Trial of RPT193 Monotherapy in Atopic Dermatitis) -AMTX +6.0% (signs $200M biofuels offtake agreement with international renewable fuels supplier Murex, LLC to be delivered during 2021 to 2023) -OCC +5.4% (earnings) -EFOI +4.8% (enters marketing partnership with FirstEnergy Home and FirstEnergy Advisors) -TWST +3.2% (collaborates with Regeneron for production of genotyping by sequencing panel to enable diverse genome-wide screening) -HGEN +2.8% (initiates Submission for Lenzilumab Marketing Authorization in COVID-19, to the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA)) -CODA +2.3% (earnings) -OTLK +2.3% (announces inclusion in the Russell 2000 Index, effective June 25, 2021) -SVOK +1.1% (confirms Boxed to go public through merger with Seven Oaks Acquisition Corp. in deal valued at ~$900M) Downside: -ATXI -47% (receives Complete Response Letter from the FDA for IV Tramadol, saying it does not support benefits as a monotherapy) -RIDE -11% (CEO and CFO resign following results of special committee investigation of Hindenburg Research report) -HEXO -3.6% (earnings) -NKLA -1.5% (discloses entered into a purchase agreement and a registration rights agreement with Tumim Stone Capital to sell $300M of the Nikola's common stock)

AMTX is setup nicely for move hihger

$AMTX recover fast

AMTX $35.00 target from Credit Suisse

$AMTX non stop

whats up with amtx

$AMTX 19FEB2021 $7.5 Cs // 10.2k+ trading vs 646 OI

$AMTX 19FEB2021 $7.5 Cs // 10.2k+ trading vs 646 OI

covered $AMTx too early though

watchlist: $VLDR, $FUBO, $JG, $AMTX

we need more plays like $AMTX. Headache free days

$AMTX down she goes

$AMTX finally giving up perhaps

bailed $AMTX

added on $AMTX

$AMTX ss the top

watching $LQDT $STIM $AMTX $TISI $FOSL